Loss of LR11/SORLA Enhances Early Pathology in a Mouse Model of Amyloidosis: Evidence for a Proximal Role in Alzheimer's Disease
Open accessAbstract
Alzheimer's disease (AD) is the most prevalent form of dementia, resulting in progressive neuronal death and debilitating damage to brain loci that mediate memory and higher cognitive function. While pathogenic genetic mutations have been implicated in ∼2% of AD cases, the proximal events that underlie the common, sporadic form of the disease are incompletely understood. Converging lines of evidence from human neuropathology, basic biology, and genetics have implicated loss of the multifunctional receptor LR11 (also known as SORLA and SORL1) in AD pathogenesis. Cell-based studies suggest that LR11 reduces the formation of β-amyloid (Aβ), the molecule believed to be a primary toxic species in AD. Recently, mutant mice deficient in LR11 were shown to upregulate murine Aβ in mouse brain. In the current study, LR11-deficient mice were crossed with transgenic mice expressing autosomal-dominant human AD genes, presenilin-1 (PS1ΔE9) and amyloid precursor protein (APPswe). Here, we show that LR11 deficiency in this AD mouse model significantly increases Aβ levels and exacerbates early amyloid pathology in brain, causing a forward shift in disease onset that is LR11 gene dose-dependent. Loss of LR11 increases the processing of the APP holo-molecule into α-, β-, and γ-secretase derived metabolites. We propose that LR11 regulates APP processing and Aβ accumulation in vivo and is of proximal importance to the cascade of pathological amyloidosis. The results of the current study support the hypothesis that control of LR11 expression may exert critical effects on Alzheimer's disease susceptibility in humans.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Reduction of LR11/SorLA protein levels increased Aβ levels and exacerbated amyloid plaque pathology in an APP/PSEN1Δ9 mouse model of amyloidosis.
“Consistent with the previous cell-based studies, reduction of LR11/SorLA protein levels increased Aβ levels and exacerbated amyloid plaque pathology in an APP/PSEN1Δ9 mouse model of amyloidosis (Dodson et al., 2008).”
From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Dodson et al., 2008
Overexpression of SORLA in neuronal cells blocks amyloidogenic processing and reduces Aβ production, whereas loss of SORLA increases extracellular Aβ levels and plaque deposition in several AD mouse models.
“Overexpression of SORLA in neuronal cells can block amyloidogenic processing and reduce Aβ production [485], whereas loss of SORLA increased extracellular Aβ levels and plaque deposition in several AD mouse models [486, 487].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [487]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404 · see citing works
Peng, J., Elias, J. E., Thoreen, C. C., Licklider, L., & Gygi, S. P. (2002) · Journal of Proteome Research · doi:10.1021/pr025556v · Cited by 1,652 · see citing works
Self-citationJankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575 · see citing works
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478 · see citing works
Self-citationIdentification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
Weidemann, A., König, G., Bunke, D., Fischer, P. Q., Salbaum, J. M., Masters, C. L., & Beyreuther, K. T. (1989) · Cell · doi:10.1016/0092-8674(89)90177-3 · Cited by 1,233 · see citing works
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167 · see citing works
Self-citationAmyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts
Ehehalt, R., Keller, P., Haass, C., Thiele, C., & Simons, K. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207113 · Cited by 1,107 · see citing works
Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., Copeland, N. G., Price, D. L., & Sisodia, S. S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80974-5 · Cited by 1,023 · see citing works
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies
Jankowsky, J. L., Slunt, H. H., Ratovitski, T., Jenkins, N. A., Copeland, N. G., & Borchelt, D. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00067-3 · Cited by 819 · see citing works
Andersen, O. M., Reiche, J., Schmidt, V., Gotthardt, M., Spoelgen, R., Behlke, J., von Arnim, C. A. F., Breiderhoff, T., Jansen, P., Wu, X., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503689102 · Cited by 655 · see citing works
Self-citationProteomics: the move to mixtures
Peng, J., & Gygi, S. P. (2001) · Journal of Mass Spectrometry · doi:10.1002/jms.229 · Cited by 648 · see citing works
Self-citationLipoprotein receptors in the nervous system
Herz, J., & Bock, H. H. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135342 · Cited by 457 · see citing works
Nielsen, M. S., Madsen, P., Christensen, E. I., Nykjær, A., Gliemann, J., Kasper, D., Pohlmann, R., & Petersen, C. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2180 · Cited by 438 · see citing works
Loss of apolipoprotein E receptor LR11 in Alzheimer disease
Scherzer, C. R., Offe, K., Gearing, M., Rees, H. D., Fang, G., Heilman, C. J., Schaller, C., Bujo, H., Levey, A. I., & Lah, J. J. (2004) · Archives of Neurology · doi:10.1001/archneur.61.8.1200 · Cited by 316 · see citing works
Self-citationOffe, K., Dodson, S. E., Shoemaker, J. T., Fritz, J. J., Gearing, M., Levey, A. I., & Lah, J. J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4946-05.2006 · Cited by 279 · see citing works
Self-citationLing, Y., Morgan, K., & Kalsheker, N. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00133-x · Cited by 224 · see citing works
Seshadri, S. S., DeStefano, A. L., Au, R., Massaro, J. M., Beiser, A., Kelly‐Hayes, M., Kase, C. S., D’Agostino, R. B., DeCarli, C. S., Atwood, L. D., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s15 · Cited by 199 · see citing works
Gralle, M., & Ferreira, S. T. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.02.001 · Cited by 191 · see citing works
Schmidt, V., Sporbert, A., Rohe, M., Reimer, T., Rehm, A., Andersen, O. M., & Willnow, T. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705073200 · Cited by 181 · see citing works
Self-citationActivation and Functional Characterization of the Mosaic Receptor SorLA/LR11
Jacobsen, L., Madsen, P., Jacobsen, C. B., Nielsen, M. S., Gliemann, J., & Petersen, C. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100857200 · Cited by 179 · see citing works
Spoelgen, R., Arnim, C. A. F. V., Thomas, A. V., Peltan, I. D., Koker, M., Deng, A., Irizarry, M. C., Andersen, O. M., Willnow, T. E., & Hyman, B. T. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3882-05.2006 · Cited by 179 · see citing works
Self-citationAndersen, O. M., Schmidt, V., Spoelgen, R., Gliemann, J., Behlke, J., Galatis, D., McKinstry, W. J., Parker, M. W., Masters, C. L., Hyman, B. T., et al. (2006) · Biochemistry · doi:10.1021/bi052120v · Cited by 178 · see citing works
Self-citationLR11/SorLA Expression Is Reduced in Sporadic Alzheimer Disease but not in Familial Alzheimer Disease
Dodson, S. E., Gearing, M., Lippa, C. F., Montine, T. J., Levey, A. I., & Lah, J. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000228205.19915.20 · Cited by 151 · see citing works
Self-citationLee, J. H., Cheng, R., Schupf, N., Manly, J. J., Lantigua, R., Stern, Y., Rogaeva, E. A., Wakutani, Y., Farrer, L. A., George‐Hyslop, P. S., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.501 · Cited by 143 · see citing works
Ma, Q., Teter, B., Ubeda, O. J., Morihara, T., Dhoot, D. S., Nyby, M. D., Tuck, M. L., Frautschy, S. A., & Cole, G. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3593-07.2007 · Cited by 115 · see citing works
Rohe, M., Carlo, A.-S., Breyhan, H., Sporbert, A., Militz, D., Schmidt, V., Wozny, C., Harmeier, A., Erdmann, B., Bales, K. R., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710574200 · Cited by 110 · see citing works
Self-citationJacobsen, L., Madsen, P., Nielsen, M. S., Geraerts, W. P. M., Gliemann, J., Smit, A. B., & Petersen, C. M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03299-9 · Cited by 105 · see citing works
Deposition of mouse amyloid β in human APP/PS1 double and single AD model transgenic mice
van Groen, T., Kiliaan, A. J., & Kadish, I. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.05.010 · Cited by 103 · see citing works
Bettens, K., Brouwers, N., Engelborghs, S., Deyn, P. P. D., Broeckhoven, C. V., & Sleegers, K. (2008) · Human Mutation · doi:10.1002/humu.20725 · Cited by 97 · see citing works
Sortilin, SorCS1b, and SorLA Vps10p sorting receptors, are novel γ-secretase substrates
Nyborg, A. C., Ladd, T. B., Zwizinski, C. W., Lah, J. J., & Golde, T. E. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-3 · Cited by 96 · see citing works
Self-citationNeuronal LR11/sorLA expression is reduced in mild cognitive impairment
Sager, K. L., Wuu, J., Leurgans, S. E., Rees, H. D., Gearing, M., Mufson, E. J., Levey, A. I., & Lah, J. J. (2007) · Annals of Neurology · doi:10.1002/ana.21190 · Cited by 96 · see citing works
Self-citationAssociation between SORL1 and Alzheimer's disease in a genome-wide study
Meng, Y., Lee, J. H., Cheng, R., George‐Hyslop, P. S., Mayeux, R. P., & Farrer, L. A. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3282f13e7a · Cited by 86 · see citing works
SorLA Signaling by Regulated Intramembrane Proteolysis
Böhm, C., Seibel, N. M., Henkel, B., Steiner, H., Haass, C., & Hampe, W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601660200 · Cited by 83 · see citing works
Sorl1 as an Alzheimer’s Disease Predisposition Gene?
Webster, J., Myers, A. J., Pearson, J. V., Craig, D. W., Hu‐Lince, D., Coon, K., Zismann, V., Beach, T., Leung, D., Bryden, L., et al. (2007) · Neurodegenerative Diseases · doi:10.1159/000110789 · Cited by 80 · see citing works
SORL1 variants and risk of late-onset Alzheimer’s disease
Li, Y., Rowland, C. M., Catanese, J. J., Morris, J. C., Lovestone, S., O’Donovan, M. C., Goate, A., Owen, M. J., Williams, J. H., & Grupe, A. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.09.001 · Cited by 79 · see citing works
ASSOCIATION BETWEEN GENETIC VARIANTS IN SORL1 AND AUTOPSY-CONFIRMED ALZHEIMER DISEASE
Lee, J. H., Cheng, R., Honig, L. S., Vonsattel, J.-P., Clark, L. N., & Mayeux, R. P. (2007) · Neurology · doi:10.1212/01.wnl.0000280581.39755.89 · Cited by 73 · see citing works
Hampe, W., Riedel, I. B., Lintzel, J., Bader, C. O., Franke, I., & Schaller, H. C. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.24.4475 · Cited by 72 · see citing works
SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese
Tan, E., Lee, J., Chen, C., Teo, Y. Y., Zhao, Y., & Lee, W. L. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.013 · Cited by 69 · see citing works
Gu, F., Luo, W., Li, X., Wang, Z., Lü, S., Zhang, M., Zhao, B., Zhu, S., Feng, S., Yan, Y., et al. (2008) · Human Mutation · doi:10.1002/humu.20724 · Cited by 55 · see citing works
Lee, J. H., Chulikavit, M., Pang, D. I., Zigman, W. B., Silverman, W. P., & Schupf, N. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.08.042 · Cited by 46 · see citing works
Mann, D. M. A., Takeuchi, A., Sato, S., Cairns, N. J., Lantos, P. L., Rossor, M. N., Haltia, M., Kalimo, H., & Iwatsubo, T. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2001.00316.x · Cited by 42 · see citing works
Gandy, S., & Petanceska, S. S. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00031-4 · Cited by 40 · see citing works
Hirayama, S., Bujo, H., Yamazaki, H., Kanaki, T., Takahashi, K., Kobayashi, J., Schneider, W. J., & Saitō, Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3312 · Cited by 24 · see citing works
Yamazaki, H., Bujo, H., & Saito, Y. (1997) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.4.20 · Cited by 23 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · see citing works
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357 · see citing works
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994 · see citing works
Fjorback, A. W., Seaman, M. N. J., Gustafsen, C., Mehmedbašić, A., Gokool, S., Wu, C., Militz, D., Schmidt, V., Madsen, P., Nyengaard, J. R., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2272-11.2012 · Cited by 253 · see citing works
Self-citationUntangling Genetic Risk for Alzheimer’s Disease
Pimenova, A. A., Raj, T., & Goate, A. M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.014 · Cited by 223 · see citing works
Zhang, W., Xu, C., Sun, J., Shen, H., Wang, J., & Yang, C. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.01.008 · Cited by 214 · see citing works
Miyashita, A., Koike, A., Jun, G., Wang, L.-S., Takahashi, S., Matsubara, E., Kawarabayashi, T., Shoji, M., Tomita, N., Arai, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058618 · Cited by 196 · see citing works
Nunes, A. F., Amaral, J. D., Lo, A. C., Fonseca, M. B., Viana, R. J. S., Callaerts-Vegh, Z., D’Hooge, R., & Rodrigues, C. M. P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8256-y · Cited by 192 · see citing works
Young, J. E., Boulanger-Weill, J., Williams, D. A., Woodruff, G., Buen, F., Revilla, A. C., Herrera, C. M., Israel, M. A., Yuan, S. H., Edland, S. D., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.02.004 · Cited by 181 · see citing works
Çağlayan, Ş., Takagi‐Niidome, S., Liao, F., Carlo, A.-S., Schmidt, V., Burgert, T., Kitago, Y., Füchtbauer, E., Füchtbauer, A. C., Holtzman, D. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007747 · Cited by 169 · see citing works
Self-citationLane, R. F., Raines, S. M., Steele, J., Ehrlich, M. E., Lah, J. J., Small, S. A., Tanzi, R. E., Attie, A., & Gandy, S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3872-10.2010 · Cited by 165 · see citing works
Self-citationIdentification of Alzheimer disease-associated variants in genes that regulate retromer function
Vardarajan, B. N., Bruesegem, S. Y., Harbour, M. E., George‐Hyslop, P. S., Seaman, M. N. J., & Farrer, L. A. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.04.020 · Cited by 162 · see citing works
Peric, A., & Annaert, W. G. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1379-7 · Cited by 162 · see citing works
Vieira, S. I., Rebelo, S., Esselmann, H., Wiltfang, J., Lah, J. J., Lane, R. F., Small, S. A., Gandy, S., Silva, E. F. D. C. E., & Silva, O. A. B. D. C. E. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-40 · Cited by 141 · see citing works
Self-citationDavis, A. A., Fritz, J. J., Wess, J., Lah, J. J., & Levey, A. I. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6393-09.2010 · Cited by 137 · see citing works
Self-citationThe genetic landscape of Alzheimer disease
Carmona, S., Hardy, J., & Guerreiro, R. J. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00026-0 · Cited by 133 · see citing works
SORL1 rare variants: a major risk factor for familial early-onset Alzheimer’s disease
Nicolas, G., Charbonnier, C., Wallon, D., Quenez, O., Bellenguez, C., Grenier-Boley, B., Rousseau, S., Richard, A.-C., Rovelet-Lecrux, A., Le Guennec, K., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.121 · Cited by 129 · see citing works
ATP-binding cassette transporter A7 (ABCA7) loss of function alters Alzheimer amyloid processing
Satoh, K., Abe-Dohmae, S., Yokoyama, S., St George-Hyslop, P., & Fraser, P. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.655076 · Cited by 128 · see citing works
Simões, A. E. S., Pereira, D. M., Amaral, J. D., Nunes, A. F., Gomes, S. E., Rodrigues, P. M., Lo, A. C., D’Hooge, R., Steer, C. J., Thibodeau, S. N., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-181 · Cited by 124 · see citing works
Sorting receptor SORLA – a trafficking path to avoid Alzheimer disease
Willnow, T. E., & Andersen, O. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.125393 · Cited by 121 · see citing works
Self-citationRohe, M., Synowitz, M., Glaß, R., Paul, S. M., Nykjær, A., & Willnow, T. E. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3960-09.2009 · Cited by 122 · see citing works
Self-citationCampion, D., Charbonnier, C., & Nicolas, G. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01991-4 · Cited by 124 · see citing works
Hung, C., Tuck, E. J., Stubbs, V. E. L., van der Lee, S. J., Aalfs, C. M., van Spaendonk, R. M. L., Scheltens, P., Hardy, J., Holstege, H. H., & Livesey, F. J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109259 · Cited by 96 · see citing works
KIBRA: a new gateway to learning and memory?
Schneider, A. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/neuro.24.004.2010 · Cited by 96 · see citing works
DHA diet reduces AD pathology in young APPswe/PS1ΔE9 transgenic mice: Possible gender effects
Perez, S. E., Berg, B. M., Moore, K. A., He, B., Counts, S., Fritz, J. J., Hu, Y., Lazarov, O., Lah, J. J., & Mufson, E. J. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22266 · Cited by 96 · see citing works
Self-citationApolipoprotein E receptors in the nervous system
Herz, J. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832d3a10 · Cited by 95 · see citing works
The Retromer Complex and Sorting Nexins in Neurodegenerative Diseases
Zhang, H., Huang, T. Y., Hong, Y., Yang, W., Zhang, X., Luo, H., Xu, H., & Wang, X. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00079 · Cited by 89 · see citing works
Beclin 1 Complex in Autophagy and Alzheimer Disease
Jaeger, P. A., & Wyss‐Coray, T. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.258 · Cited by 90 · see citing works
Risk factor SORL1: from genetic association to functional validation in Alzheimer’s disease
Andersen, O. M., Rudolph, I., & Willnow, T. E. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1615-4 · Cited by 89 · see citing works
Self-citationSORL1 mutations in early- and late-onset Alzheimer disease
Cuccaro, M. L., Carney, R. M., Zhang, Y., Böhm, C., Kunkle, B. W., Vardarajan, B. N., Whitehead, P. L., Cukier, H. N., Mayeux, R. P., George‐Hyslop, P. S., et al. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000116 · Cited by 82 · see citing works
Gong, B., Chen, F., Pan, Y., Arrieta‐Cruz, I., Yoshida, Y., Haroutunian, V. H., & Pasinetti, G. M. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00632.x · Cited by 82 · see citing works
Lipid Metabolism and Glial Lipoproteins in the Central Nervous System
Hayashi, H. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.453 · Cited by 80 · see citing works
α 2A adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction
Chen, Y., Peng, Y., Che, P., Gannon, M. A., Liu, Y., Li, L., Bu, G., van Groen, T., Jiao, K., & Wang, Q. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409513111 · Cited by 79 · see citing works
Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease
Schmidt, V., Baum, K., Lao, A., Rateitschak, K., Schmitz, Y., Teichmann, A., Wiesner, B., Petersen, C. M., Nykjaer, A., Wolf, J., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.352 · Cited by 75 · see citing works
Self-citationCholesterol-related genes in Alzheimer's disease
Wollmer, M. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.05.009 · Cited by 77 · see citing works
Rivera-Escalera, F., Pinney, J. J., Owlett, L., Ahmed, H., Thakar, J., Olschowka, J. A., Elliott, M. R., & O’Banion, M. K. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1645-7 · Cited by 75 · see citing works
Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans
Whittle, A. J., Jiang, M., Peirce, V. J., Relat, J., Virtue, S., Ebinuma, H., Fukamachi, I., Yamaguchi, T., Takahashi, M., Murano, T., et al. (2015) · Nature Communications · doi:10.1038/ncomms9951 · Cited by 71 · see citing works
Sorting receptor SORLA: cellular mechanisms and implications for disease
Schmidt, V., Subkhangulova, A., & Willnow, T. E. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2410-z · Cited by 65 · see citing works
Self-citationAlzheimer’s disease and the autophagic-lysosomal system
Chung, K. M., Hernández, N., Sproul, A. A., & Yu, W. H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.05.017 · Cited by 63 · see citing works
Structural basis for amyloidogenic peptide recognition by sorLA
Kitago, Y., Nagae, M., Nakata, Z., Yagi‐Utsumi, M., Takagi‐Niidome, S., Mihara, E., Nogi, T., Kato, K., & Takagi, J. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2954 · Cited by 62 · see citing works
Andrew, R. J., De Rossi, P., Nguyen, P., Kowalski, H. R., Recupero, A. J., Guerbette, T., Krause, S. V., Rice, R. C., Laury-Kleintop, L., Wagner, S. L., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006379 · Cited by 55 · see citing works
SorLA Complement-type Repeat Domains Protect the Amyloid Precursor Protein against Processing
Mehmedbašić, A., Christensen, S. K., Nilsson, J., Rüetschi, U., Gustafsen, C., Poulsen, A. S. A., Rasmussen, R. W., Fjorback, A. N., Larson, G., & Andersen, O. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.619940 · Cited by 56 · see citing works
Self-citationExpression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain
Grear, K. E., Ling, I.-F., Simpson, J. F., Furman, J. L., Simmons, C. R., Peterson, S. L., Schmitt, F. A., Markesbery, W. R., Liu, Q., Crook, J. E., et al. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-46 · Cited by 56 · see citing works
Rho Kinase II Phosphorylation of the Lipoprotein Receptor LR11/SORLA Alters Amyloid-β Production
Herskowitz, J. H., Seyfried, N. T., Gearing, M., Kahn, R., Peng, J., Levey, A. I., & Lah, J. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.167239 · Cited by 55 · see citing works
Self-citationDong, H. K., Gim, J., Yeo, S. H., & Kim, H. (2016) · Gene · doi:10.1016/j.gene.2016.10.022 · Cited by 54 · see citing works
Herskowitz, J. H., Offe, K., Deshpande, A., Kahn, R., Levey, A. I., & Lah, J. J. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-01-0014 · Cited by 56 · see citing works
Self-citationA genetically modified minipig model for Alzheimer’s disease with SORL1 haploinsufficiency
Andersen, O. M., Bøgh, N., Landau, A. M., Pløen, G. G., Jensen, A. M. G., Monti, G., Ulhøi, B. P., Nyengaard, J. R., Jacobsen, K. R., Jørgensen, A. L., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100740 · Cited by 53 · see citing works
Self-citationLee, H., Aylward, A. J., Pearse, R. V., Lish, A. M., Hsieh, Y., Augur, Z. M., Benoit, C. R., Chou, V., Knupp, A., Pan, C., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112994 · Cited by 53 · see citing works
Impact of late-onset Alzheimer’s genetic risk factors on beta-amyloid endocytic production
Almeida, C. G., Mirfakhar, F. S., Perdigão, C., & Burrinha, T. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2825-9 · Cited by 48 · see citing works
CDT2‐controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease
Huang, F., Wang, M., Liu, R., Wang, J., Schadt, E., Haroutunian, V., Katsel, P., Zhang, B., & Wang, X. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.08.013 · Cited by 47 · see citing works
From beta amyloid to altered proteostasis in Alzheimer’s disease
Bruni, A. C., Bernardi, L., & Gabelli, C. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101126 · Cited by 47 · see citing works
Eggert, S., Kins, S., Endres, K., & Brigadski, T. (2022) · Biological Chemistry · doi:10.1515/hsz-2021-0330 · Cited by 46 · see citing works
The Resveratrol Trimer Miyabenol C Inhibits β-Secretase Activity and β-Amyloid Generation
Hu, J., Lin, T., Gao, Y., Xu, J., Jiang, C., Wang, G.-H., Bu, G.-J., Xu, H.-X., Chen, H., & Zhang, Y.-W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115973 · Cited by 40 · see citing works
ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA
Yajima, R., Tokutake, T., Koyama, A., Kasuga, K., Tezuka, T., Nishizawa, M., & Ikeuchi, T. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.11.111 · Cited by 43 · see citing works
Sorting Out the Role of the Sortilin-Related Receptor 1 in Alzheimer’s Disease
Barthelson, K., Newman, M., & Lardelli, M. T. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200177 · Cited by 42 · see citing works
Marks, N., & Berg, M. J. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0054-1 · Cited by 38 · see citing works
Çağlayan, Ş. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.788 · Cited by 40 · see citing works
SORLA-Mediated Trafficking of TrkB Enhances the Response of Neurons to BDNF
Rohe, M., Hartl, D., Fjorback, A. N., Klose, J., & Willnow, T. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072164 · Cited by 39 · see citing works
Self-citationGolgi fragmentation – One of the earliest organelle phenotypes in Alzheimer’s disease neurons
Haukedal, H., Corsi, G. I., Gadekar, V. P., Doncheva, N. T., Kedia, S., de Haan, N., Chandrasekaran, A., Jensen, P., Schiønning, P., Vallin, S., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1120086 · Cited by 37 · see citing works
Rovelet‐Lecrux, A., Feuillette, S., Miguel, L., Schramm, C., Pernet, S., Quenez, O., Ségalas-Milazzo, I., Guilhaudis, L., Rousseau, S., Riou, G., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01294-4 · Cited by 38 · see citing works
Impaired spare respiratory capacity in cortical synaptosomes from Sod2 null mice
Flynn, J. M., Choi, S. W., Day, N. U., Gerencser, A. A., Hubbard, A., & Melov, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.030 · Cited by 37 · see citing works
Wen, Y., Initiative, J. A. D. N., Miyashita, A., Kitamura, N., Tsukie, T., Saito, Y., Hatsuta, H., Murayama, S., Kakita, A., Takahashi, H., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122395 · Cited by 37 · see citing works
Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer’s disease
Salašová, A., Monti, G., Andersen, O. M., & Nykjær, A. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00576-2 · Cited by 35 · see citing works
Self-citationTraffic jam hypothesis: Relationship between endocytic dysfunction and Alzheimer's disease
Kimura, N., & Yanagisawa, K. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.07.002 · Cited by 37 · see citing works
Sortilin and SorLA Regulate Neuronal Sorting of Trophic and Dementia-Linked Proteins
Pallesen, L. T., & Vægter, C. B. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8236-2 · Cited by 31 · see citing works
The influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease
Louwersheimer, E., Ramı́rez, A., Cruchaga, C., Becker, T., Kornhuber, J., Peters, O., Heilmann‐Heimbach, S., Wiltfang, J., Jessen, F., Visser, P. J., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.007 · Cited by 34 · see citing works
SORLA-Dependent and -Independent Functions for PACS1 in Control of Amyloidogenic Processes
Burgert, T., Schmidt, V., Çağlayan, Ş., Lin, F., Füchtbauer, A. C., Füchtbauer, E., Nykjær, A., Carlo, A.-S., & Willnow, T. E. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00628-13 · Cited by 33 · see citing works
Self-citationJin, Z. H., Kim, K. E., Shin, H. J., Jeong, E. A., Park, K.-A., Lee, J. Y., An, H. S., Choi, E. B., Jeong, J. H., Kwak, W., et al. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa017 · Cited by 33 · see citing works
Jensen, A. M. G., Kitago, Y., Fazeli, E., Vægter, C. B., Small, S. A., Petsko, G. A., & Andersen, O. M. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2212180120 · Cited by 33 · see citing works
Self-citationZollo, A., Allen, Z., Rasmussen, H. F., Iannuzzi, F., Shi, Y., Larsen, A., Maier, T. J., & Matrone, C. (2017) · Neural Plasticity · doi:10.1155/2017/1892612 · Cited by 32 · see citing works
The role of lipoprotein receptors on the physiological function of APP
Wagner, T., & Pietrzik, C. U. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2876-8 · Cited by 31 · see citing works
Rosa, L. R. L., Perrone, L., Nielsen, M. S., Calissano, P., Andersen, O. M., & Matrone, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00109 · Cited by 31 · see citing works
Self-citationMishra, S., Knupp, A., Kinoshita, C., Williams, C. A., Rose, S. E., Martinez, R. A., Theofilas, P., & Young, J. E. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.10.011 · Cited by 30 · see citing works
Chou, C., Liao, Y., Lee, W., Wang, S., & Fuh, J. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0222-x · Cited by 29 · see citing works
Schramm, C., Charbonnier, C., Zaréa, A., Lacour, M., Wallon, D., collaborators, C., Andriuta, D., Anthony, P., Auriacombe, S., Balageas, A., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01070-6 · Cited by 26 · see citing works
Herrmann, L., Wiegmann, C., Arsalan-Werner, A., Hilbrich, I., Jäger, C., Flach, K., Suttkus, A., Lachmann, I., Arendt, T., & Holzer, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119423 · Cited by 25 · see citing works
Medoro, A., Bartollino, S., Mignogna, D., Passarella, D., Porcile, C., Pagano, A., Florio, T., Nizzari, M., Guerra, G., Marco, R. D., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170628 · Cited by 24 · see citing works
Alexopoulos, P., Guo, L., Tsolakidou, A. F., Kratzer, M., Grimmer, T., Westerteicher, C., Jiang, M., Bujo, H., Diehl‐Schmid, J., Kurz, A., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110983 · Cited by 23 · see citing works
SORLA/SORL1, a Neuronal Sorting Receptor Implicated in Alzheimer's Disease
Willnow, T. E., Carlo, A.-S., Rohe, M., & Schmidt, V. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.4.315 · Cited by 22 · see citing works
Self-citationTsolakidou, A. F., Alexopoulos, P., Guo, L., Grimmer, T., Westerteicher, C., Kratzer, M., Jiang, M., Bujo, H., Roselli, F., Leante, M. R., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.01.015 · Cited by 19 · see citing works
Sortilin inhibits amyloid pathology by regulating non-specific degradation of APP
Ruan, C., Liu, J., Yang, M., Saadipour, K., Zeng, Y.-Q., Liao, H., Wang, Y., Bobrovskaya, L., & Zhou, X. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.10.018 · Cited by 18 · see citing works
Capsoni, S., Carlo, A.-S., Vignone, D., Amato, G., Criscuolo, C., Willnow, T. E., & Cattaneo, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121399 · Cited by 17 · see citing works
Self-citationMiyashita, A., Koike, A., Jun, G., Wang, L., Takahashi, S., Matsubara, E., Kawarabayashi, T., Shoji, M., Tomita, N., Arai, H., et al. (2013) · PLoS ONE · doi:10.1371/annotation/fcb56ea7-d32a-4e45-818d-39cef330c731 · Cited by 17 · see citing works
Sorting the Role of SORLA in Alzheimer’s Disease
Buggia-Prévot, V., & Thinakaran, G. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008562 · Cited by 16 · see citing works
SORL1 Variants in Familial Alzheimer’s Disease
Gómez‐Tortosa, E., Ruggiero, M., Sainz, M. J., Villarejo‐Galende, A., Jurczynska, C. P., Pérez, B. V., Ordás, C., Agüero, P., Guerrero, R., & Pérez‐Pérez, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170590 · Cited by 15 · see citing works
An alternative transcript of the Alzheimer's disease risk gene SORL1 encodes a truncated receptor
Blechingberg, J., Poulsen, A. S. A., Kjølby, M., Monti, G., Allen, M., Ivarsen, A. K., Lincoln, S., Thotakura, G., Vægter, C. B., Ertekin‐Taner, N., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.021 · Cited by 15 · see citing works
Self-citationGenetics of neuropsychiatric symptoms in patients with Alzheimer's disease: A 1‐year follow‐up study
Huang, M., Lee, W., Yeh, Y., Liao, Y., Wang, S., Yang, Y., Chen, C., & Fuh, J. (2020) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13150 · Cited by 15 · see citing works
Multi-compartmental modeling of SORLA’s influence on amyloidogenic processing in Alzheimer’s disease
Lao, A. R., Schmidt, V., Schmitz, Y., Willnow, T. E., & Olaf Wolkenhauer, A. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-74 · Cited by 13 · see citing works
Self-citationSORLA regulates calpain‐dependent degradation of synapsin
Hartl, D., Nebrich, G., Klein, O., Stephanowitz, H., Krause, E., & Rohe, M. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.02.008 · Cited by 13 · see citing works
Amyloidosis causes downregulation of SorLA, SorCS1 and SorCS3 expression in mice
Hermey, G., Hoffmeister‐Ullerich, S., Merz, B., Groß, D., Kuhl, D., & Kins, S. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0146 · Cited by 13 · see citing works
Monti, G., Kjølby, M., Jensen, A. M. G., Allen, M., Reiche, J., Møller, P. L., Baro, R. C., Zolkowski, B. E., Vieira, C. S. D. C. A., Jørgensen, A. L., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01140-7 · Cited by 13 · see citing works
Self-citationSager, K. L., Wuu, J., Herskowitz, J. H., Mufson, E. J., Levey, A. I., & Lah, J. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040527 · Cited by 12 · see citing works
Self-citationApolipoprotein E receptor pathways in Alzheimer disease
Schmidt, V., Carlo, A.-S., & Willnow, T. E. (2014) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1262 · Cited by 10 · see citing works
Self-citationNeuronal Trafficking of the Amyloid Precursor Protein—What Do We Really Know?
Lin, T., Tjernberg, L. O., & Schedin‐Weiss, S. (2021) · Biomedicines · doi:10.3390/biomedicines9070801 · Cited by 10 · see citing works
Mishra, S., Knupp, A., Kinoshita, C., Williams, C. A., Rose, S. E., Martinez, R. A., Theofilas, P., & Young, J. E. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.31.502217 · Cited by 9 · see citing works
Hao, M., Chu, J., Zhang, T., Yin, T., Gu, Y., Liang, W., Ji, W., Zhuang, J., Liu, Y., Gao, J., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01736 · Cited by 8 · see citing works
Membrane trafficking and proteolytic activity of γ-secretase in Alzheimer’s disease
Kanatsu, K., & Tomita, T. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0146 · Cited by 8 · see citing works
Beware of Misdelivery: Multifaceted Role of Retromer Transport in Neurodegenerative Diseases
Yoshida, S., & Hasegawa, T. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.897688 · Cited by 8 · see citing works
Bøgh, N., Sørensen, C. B., Alstrup, A. K. O., Hansen, E. S. S., Andersen, O. M., & Laustsen, C. (2024) · Brain Communications · doi:10.1093/braincomms/fcae114 · Cited by 7 · see citing works
Self-citationSorLA in astrocytes regulates blood-brain barrier integrity
Tóth, A. E., Klepe, A., Lipka, D. V., Goldeman, C., Brodin, B., & Nielsen, M. S. (2023) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.1082689 · Cited by 7 · see citing works
- Authors
- Dodson, S. E., Andersen, O. M., Karmali, V., Fritz, J. J., Cheng, D., Peng, J., Levey, A. I., Willnow, T. E., & Lah, J. J.
- Affiliations
- Emory University (US)
- Aarhus University (DK)
- Max Delbrück Center (DE)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2008-11-26
- Volume
- 28
- Issue
- 48
- Pages
- 12877-12886
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2669320
- OpenAlex
- W1967519462
- Cited by
- 141
- References
- 44
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 8 · 2022: 8 · 2021: 9 · 2020: 7 · 2019: 7 · 2018: 9 · 2017: 7 · 2016: 9 · 2015: 12 · 2014: 10 · 2013: 8 · 2012: 12
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Journal of Neuroscience Nursing
- Funders
- Deutsche Forschungsgemeinschaft
- National Institutes of Health (AG05136)
- National Institute on Aging (R01AG024214, AG 05136, P50AG005136)
- National Institute of Neurological Disorders and Stroke (F31NS055881)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- LR11, SorLA, SORL1, Alzheimer's disease, amyloidosis, amyloid-beta, APP processing, presenilin 1, APPswe, gene dosage, disease onset, transgenic mouse model
- MeSH terms
- Alzheimer Disease, Amyloidosis, Animals, Brain, Disease Models, Animal, Gene Expression Regulation, Humans, Mice, Transgenic, Neurons, Receptors, LDL, Up-Regulation, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Mice, Knockout, Gene Dosage, Genetic Predisposition to Disease, Membrane Transport Proteins, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
